KALA BIO, Inc. (KALA) Financials

KALA Assets vs Liabilities
DateAssetsLiabilities
Sept. 30, 2025 25.0 million 33.7 million
June 30, 2025 36.1 million 39.3 million
March 31, 2025 48.3 million 42.5 million
Dec. 31, 2024 55.5 million 43.2 million

KALA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2025 -10.9 million 2.0 million
June 30, 2025 -7.7 million 2.2 million
March 31, 2025 -8.8 million 2.3 million
Dec. 31, 2024 -4.7 million 2.1 million

KALA Net Income

No data available :(

KALA Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2025 21.1 million 1.1 million 1.5 million
June 30, 2025 31.9 million 18.8 million 1.6 million
March 31, 2025 42.2 million 15.1 million 1.7 million
Dec. 31, 2024 51.2 million 20.1 million 1.8 million

KALA Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2025 7.0 million
June 30, 2025 6.5 million
March 31, 2025 6.3 million
Dec. 31, 2024 4.7 million

KALA Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2025 16000 6.1 million 4.5 million -
June 30, 2025 - 6.2 million 4.6 million -
March 31, 2025 - 6.1 million 4.6 million -
Dec. 31, 2024 69000 5.2 million 4.2 million -

KALA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2025 - -
June 30, 2025 - 67000
March 31, 2025 - -
Dec. 31, 2024 254000 69000

KALA Revenue by Segment
Graph available only for paid members. Upgrade to see it.

KALA

Price: $3.61

52 week price:
2.03
1030.00

Earnings Per Share: -5.64 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 3.0 million

Ebitda: -9.9 million

Market Capitalization: 45.2 million

Links: